In L4–6 DRG, TET1 was found in the cytoplasm and nucleus, and it was presumed to potentially enhance the progression of bone cancer pain through nuclear translocation to modulate gene expression through DNA demethylation processes. The gene discussed is TET1; the disease is bone neoplasm.